findmyKOL

Bjorn Oskarsson, MD

Enriched profile

Consultant and Associate Professor of Neurology; Director, ALS Center of Excellence (Director, ALS and MDA Clinics Jacksonville) · Mayo Clinic

ORCIDNPI
Region🇺🇸 Jacksonville, FL · Southeast · United StatesSpecialtyNeurologyFocusALS
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2020–2025

Bjorn Oskarsson is Consultant and Associate Professor of Neurology; Director, ALS Center of Excellence (Director, ALS and MDA Clinics Jacksonville) at Mayo Clinic. OpenAlex indexes 166 publications with 5,409 citations (h-index 38); ClinicalTrials.gov lists 16 registered studies with this person as an investigator.

Data verified 25 Aug 2026

Overview

Updated 1 Sept 2026

Bjorn Oskarsson, MD, is Consultant and Associate Professor of Neurology at Mayo Clinic, Jacksonville, Florida. The public record shows 166 publications with 5,409 citations (h-index 38), centered on ALS. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 4 companies, 2 NIH-funded awards (2020–2025).

  • Most recent indexed publication: 2026 · Annals of neurology
  • Top research focus: ALS
  • 16 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ALS14 trialsMotor Neuron Disease14 trialsMuscle Cramp1 trialMovement Disorders1 trial

Research focus

OpenAlex concept fingerprint
ALS

Drugs & molecules

across trials, industry payments and publications
Radicavageneric · EdaravoneClinical trialsIndustry payments4PublicationsSpinrazageneric · NusinersenClinical trialsIndustry payments3Publications

Works with

trial sponsors and companies reporting payments
Corcept TherapeuticsClinical trialsIndustry payments10Mayo ClinicClinical trials6Industry paymentsBiogen, Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
166publications

Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.

5,409citations

Total citations across indexed works.

38h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16clinical trials

Investigator role on registered studies.

View trials
4companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
2NIH grants · 2020–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 1 Sept 2026

4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.2%
    Other nervous system drugs38.1%
    Radicava Ors100%
    Part D24 patients
    Benzothiazole30.8%
    Riluzole100%
    Part D41 patients
  • Musculoskeletal

    4.8%
    gamma-Aminobutyric Acid-ergic Agonist4.8%
    Baclofen100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 1 Sept 2026

2 NIH research awards on record, funded 20202025 per NIH RePORTER. The latest:

Publications

Updated 1 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/bj%C3%B6rn-oskarsson-md-faan-8792a2104

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Bjorn-Oskarsson

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • Doximity

    doximity.com/pub/bjorn-oskarsson-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/DK-BqI6M6LY

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Instagram

    instagram.com/reel/DOgYqCADjSj

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com
  • X / Twitter

    x.com/MGHNeurology/status/1954908405958664514

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
7 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Executive Committee Member-at-Large

    NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tools.neals.org
  • Member

    ALS Association; Western ALS Study Group; California ALS Clinical Committee; World Federation of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tools.neals.org

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.